Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (111-120 of 766) with videos related to

Pageof 77
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Increased incidence of fractures in recipients of hematopoietic stem-cell transplantationXerxes N Pundole, Andrea G Barbo, Heather Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Fifty years of melphalan use in hematopoietic stem cell transplantationUlas D Bayraktar, Qaiser Bashir, Muzaffar Qazilbash, et al.
Medical and Pediatric Oncology|January 1, 1984
AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemiaR Boccia, J Zighelboim, R E Champlin, et al.
Critical Reviews in Immunology|January 7, 1998
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicityA Choudhury, A Toubert, S Sutaria, et al.
The Journal of Clinical Investigation|October 1, 1986
Designed transfer of specific immune responses with bone marrow transplantationA Saxon, R Mitsuyasu, R Stevens, et al.
Cancer Research|June 11, 1999
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemiaJ J Molldrem, P P Lee, C Wang, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancerM L Donato, R E Champlin, J T Wharton, et al.
Bone Marrow Transplantation|October 1, 1993
B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?J Storek, S Ferrara, N Ku, et al.
Blood|February 15, 1989
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factorR E Champlin, S D Nimer, P Ireland, et al.
American Journal of Blood Research|September 3, 2013
Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantationLimei Michelle Poon, Antonio Di Stasi, Uday Popat, et al.
Pageof 77

Showing results (111-120 of 766) with videos related to

Sort By:
Pageof 77
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Increased incidence of fractures in recipients of hematopoietic stem-cell transplantationXerxes N Pundole, Andrea G Barbo, Heather Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2012
Fifty years of melphalan use in hematopoietic stem cell transplantationUlas D Bayraktar, Qaiser Bashir, Muzaffar Qazilbash, et al.
Medical and Pediatric Oncology|January 1, 1984
AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemiaR Boccia, J Zighelboim, R E Champlin, et al.
Critical Reviews in Immunology|January 7, 1998
Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicityA Choudhury, A Toubert, S Sutaria, et al.
The Journal of Clinical Investigation|October 1, 1986
Designed transfer of specific immune responses with bone marrow transplantationA Saxon, R Mitsuyasu, R Stevens, et al.
Cancer Research|June 11, 1999
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemiaJ J Molldrem, P P Lee, C Wang, et al.
European Journal of Gynaecological Oncology|August 19, 2000
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancerM L Donato, R E Champlin, J T Wharton, et al.
Bone Marrow Transplantation|October 1, 1993
B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?J Storek, S Ferrara, N Ku, et al.
Blood|February 15, 1989
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factorR E Champlin, S D Nimer, P Ireland, et al.
American Journal of Blood Research|September 3, 2013
Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantationLimei Michelle Poon, Antonio Di Stasi, Uday Popat, et al.
Pageof 77